The role of short-chain fatty acids in inflammatory bowel diseases and colorectal cancer.
DOI:
https://doi.org/10.18388/pb.2021_396Abstract
Short-chain fatty acids (SCFAs) produced in the human colon are the major products of bacterial fermentation and are believed that they have a protective effect in case of gastrointestinal diseases. SCFAs, such as acetate, propionate, and butyrate are significant metabolites in intestinal homeostasis, and have been shown to be beneficial in inflammatory bowel diseases and colorectal cancer. SCFA are responsible for maintaining proper intestinal barrier and they take part in relevant immune functions. Action of SCFAs is dependent on the activation of protein receptors for receptor activation (GPCR) such as GPR41, GPR43 and GPR109A. In this review, we discuss the effects of SCFA on the intestinal mucosa in terms of inflammatory diseases and colorectal cancer.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Advances in Biochemistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
All journal contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made, ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. There are no additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright for all published papers © stays with the authors.
Copyright for the journal: © Polish Biochemical Society.
